Sheets Smith Investment Management Harmony Biosciences Holdings, Inc. Transaction History
Sheets Smith Investment Management
- $89.3 Million
- Q4 2022
A detailed history of Sheets Smith Investment Management transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Sheets Smith Investment Management holds 11,367 shares of HRMY stock, worth $341,010. This represents 0.7% of its overall portfolio holdings.
Number of Shares
11,367
Previous 11,884
4.35%
Holding current value
$341,010
Previous $559,000
11.99%
% of portfolio
0.7%
Previous 0.65%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$337 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$178 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$109 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$78.2 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$74.8 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.77B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...